As CD4+ T-cell help and cross-presenting cDC1s enhance polyfunctional intra-tumoral CD8+ T cells and prevent rapid CD8+ T-cell exhaustion or energy, future efforts should focus on designing the optimal cancer vaccine constructs to guarantee the migration of these crucial immune cell subsets to their site of action. Here, CD4 is linked to cancer.